Role of lymphatic vasculature in regional and distant metastases

Microvascular Research

Volumn 95, Issue 1, 2014, Pages 46-52

  Podgrabinska, Simona ^a   Skobe, Mihaela ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Tisch Cancer Institute at Mount Sinai   (United States)

Author keywords

CCL1; CCR8; Chemokine; Immunoregulation; Lymph node; Lymphangiogenesis; Lymphatic endothelium; Metastasis; VEGF C; VEGFR 3

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR8; PROGRAMMED DEATH 1 RECEPTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; SPHINGOSINE 1 PHOSPHATE; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

CANCER CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARCINOMATOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; DENDRITIC CELL; DISTANT METASTASIS; DOWN REGULATION; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHOCYTE; MELANOMA; NONHUMAN; PATHOGENESIS; REVIEW; SENTINEL LYMPH NODE; T LYMPHOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ADAPTIVE IMMUNITY; ANIMAL; ENDOTHELIUM CELL; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

ADAPTIVE IMMUNITY; ANIMALS; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; NEOPLASMS; PROGNOSIS;

EID: 84922213793     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2014.07.004     Document Type: Review

References (114)

1. Acikgoz G., Kim S.M., Houseni M., Cermik T.F., Intenzo C.M., Alavi A. Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings. Clin. Nucl. Med. 2006, 31:673-678.
2. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-227.
3. Amundson D.E., Weiss P.J. Hypoxemia in malignant carcinoid syndrome: a case attributed to occult lymphangitic metastatic involvement. Mayo Clin. Proc. 1991, 66:1178-1180.
4. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., Jessberger R., Merad M., Randolph G.J. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006, 24:203-215.
5. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis 2008, 25:345-356.
6. Brahmer J.R., Tykodi S.S., Chow L.Q., Hwu W.J., Topalian S.L., Hwu P., Drake C.G., Camacho L.H., Kauh J., Odunsi K., et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 2012, 366:2455-2465.
7. Brakenhielm E., Burton J.B., Johnson M., Chavarria N., Morizono K., Chen I., Alitalo K., Wu L. Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int. J. Cancer 2007, 121:2153-2161.
8. Braun A., Worbs T., Moschovakis G.L., Halle S., Hoffmann K., Bolter J., Munk A., Forster R. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 2011, 12:879-887.
9. Bruce D.M., Heys S.D., Eremin O. Lymphangitis carcinomatosa: a literature review. J. R. Coll. Surg. Edinb. 1996, 41:7-13.
10. Burton J.B., Priceman S.J., Sung J.L., Brakenhielm E., An D.S., Pytowski B., Alitalo K., Wu L. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. 2008, 68:7828-7837.
11. Cabioglu N., Yazici M.S., Arun B., Broglio K.R., Hortobagyi G.N., Price J.E., Sahin A. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin. Cancer Res. 2005, 11:5686-5693.
12. Card C.M., Yu S.S., Swartz M.A. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J. Clin. Invest. 2014, 124:943-952.
13. Carr I. Lymphatic metastasis. Cancer Metastasis Rev. 1983, 2:307-317.
14. Carr I., Levy M., Orr K., Bruni J. Lymph node metastasis and cell movement: ultrastructural studies on the rat 13762 mammary carcinoma and Walker carcinoma. Clin. Exp. Metastasis 1985, 3:125-139.
15. Chen Z., Varney M.L., Backora M.W., Cowan K., Solheim J.C., Talmadge J.E., Singh R.K. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res. 2005, 65:9004-9011.
16. Clasper S., Royston D., Baban D., Cao Y., Ewers S., Butz S., Vestweber D., Jackson D.G. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res. 2008, 68:7293-7303.
17. Cohen J.N., Guidi C.J., Tewalt E.F., Qiao H., Rouhani S.J., Ruddell A., Farr A.G., Tung K.S., Engelhard V.H. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 2010, 207:681-688.
18. Dadiani M., Kalchenko V., Yosepovich A., Margalit R., Hassid Y., Degani H., Seger D. Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res. 2006, 66:8037-8041.
19. Dadras S.S., Lange-Asschenfeldt B., Velasco P., Nguyen L., Vora A., Muzikansky A., Jahnke K., Hauschild A., Hirakawa S., Mihm M.C., Detmar M. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod. Pathol. 2005, 18:1232-1242.
20. Das S., Skobe M. Lymphatic vessel activation in cancer. Ann. N. Y. Acad. Sci. 2008, 1131:235-241.
21. Das S., Ladell D.S., Podgrabinska S., Ponomarev V., Nagi C., Fallon J.T., Skobe M. Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases. Cancer Res. 2010, 70:1814-1824.
22. Das S., Sarrou E., Podgrabinska S., Cassella M., Mungamuri S.K., Feirt N., Gordon R., Nagi C.S., Wang Y., Entenberg D., et al. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J. Exp. Med. 2013, 210:1509-1528.
23. Dewar D.J., Newell B., Green M.A., Topping A.P., Powell B.W., Cook M.G. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol. 2004, 22:3345-3349.
24. Ding S., Li C., Lin S., Han Y., Yang Y., Zhang Y., Li L., Zhou L., Kumar S. Distinct roles of VEGF-A and VEGF-C in tumour metastasis of gastric carcinoma. Oncol. Rep. 2007, 17:369-375.
25. Edge S.B. AJCC Cancer Staging Manual 2010, Springer. 7th edn.
26. Fichera G., Hagerstrand I. The small lymph vessels of the lungs in lymphangiosis carcinomatosa. Acta Pathol. Microbiol. Scand. 1965, 65:505-513.
27. Fletcher A.L., Lukacs-Kornek V., Reynoso E.D., Pinner S.E., Bellemare-Pelletier A., Curry M.S., Collier A.R., Boyd R.L., Turley S.J. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 2010, 207:689-697.
28. Forster R., Davalos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008, 8:362-371.
29. Furudoi A., Tanaka S., Haruma K., Kitadai Y., Yoshihara M., Chayama K., Shimamoto F. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 2002, 62:157-166.
30. Gardner J.M., Devoss J.J., Friedman R.S., Wong D.J., Tan Y.X., Zhou X., Johannes K.P., Su M.A., Chang H.Y., Krummel M.F., Anderson M.S. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008, 321:843-847.
31. Girard J.P., Moussion C., Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 2012, 12:762-773.
32. Goldsmith H.S., Bailey H.D., Callahan E.L., Beattie E.J. Pulmonary lymphangitic metastases from breast carcinoma. Arch. Surg. 1967, 94:483-488.
33. Grigorova I.L., Schwab S.R., Phan T.G., Pham T.H., Okada T., Cyster J.G. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat. Immunol. 2009, 10:58-65.
34. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:258-263.
35. Haessler U., Pisano M., Wu M., Swartz M.A. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5614-5619.
36. Harold J.T. Lymphangitis carcinomatosa of the lungs. Q. J. Med. 1952, 21:353-360.
37. Harrell M.I., Iritani B.M., Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 2007, 170:774-786.
38. Hayashi K., Jiang P., Yamauchi K., Yamamoto N., Tsuchiya H., Tomita K., Moossa A.R., Bouvet M., Hoffman R.M. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 2007, 67:8223-8228.
39. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., Harding T., Jooss K., Takahashi T., Alitalo K. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 2005, 65:4739-4746.
40. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 2005, 201:1089-1099.
41. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007, 109:1010-1017.
42. Hirakawa S., Detmar M., Kerjaschki D., Nagamatsu S., Matsuo K., Tanemura A., Kamata N., Higashikawa K., Okazaki H., Kameda K., et al. Nodal lymphangiogenesis and metastasis: role of tumor-induced lymphatic vessel activation in extramammary Paget's disease. Am. J. Pathol. 2009, 175:2235-2248.
43. Houshmand P., Zlotnik A. Therapeutic applications in the chemokine superfamily. Curr. Opin. Chem. Biol. 2003, 7:457-460.
44. Irjala H., Johansson E.L., Grenman R., Alanen K., Salmi M., Jalkanen S. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J. Exp. Med. 2001, 194:1033-1042.
45. Irjala H., Alanen K., Grenman R., Heikkila P., Joensuu H., Jalkanen S. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res. 2003, 63:4671-4676.
46. Ishigami S., Natsugoe S., Nakajo A., Tokuda K., Uenosono Y., Arigami T., Matsumoto M., Okumura H., Hokita S., Aikou T. Prognostic value of CCR7 expression in gastric cancer. Hepatogastroenterology 2007, 54:1025-1028.
47. Jakubzick C., Tacke F., Llodra J., van Rooijen N., Randolph G.J. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 2006, 176:3578-3584.
48. Janower M.L., Blennerhassett J.B. Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification. Radiology 1971, 101:267-273.
49. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997, 276:1423-1425.
50. Jia L., Xie Z., Zheng J., Liu L., He Y., Liu F. Morphological studies of lymphatic labyrinths in the rat mesenteric lymph node. Anat. Rec. (Hoboken) 2012, 295:1291-1301.
51. Johnson L.A., Jackson D.G. Cell traffic and the lymphatic endothelium. Ann. N. Y. Acad. Sci. 2008, 1131:119-133.
52. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996, 15:290-298.
53. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997, 16:3898-3911.
54. Kawakami M., Yanai Y., Hata F., Hirata K. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model. Surg. Today 2005, 35:131-138.
55. Kerjaschki D., Regele H.M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., Birner P., Krieger S., Hovorka A., Silberhumer G., et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 2004, 15:603-612.
56. Kerjaschki D., Bago-Horvath Z., Rudas M., Sexl V., Schneckenleithner C., Wolbank S., Bartel G., Krieger S., Kalt R., Hantusch B., et al. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J. Clin. Invest. 2011, 121:2000-2012.
57. Kim M., Koh Y.J., Kim K.E., Koh B.I., Nam D.H., Alitalo K., Kim I., Koh G.Y. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 2010, 70:10411-10421.
58. Kim H., Kataru R.P., Koh G.Y. Regulation and implications of inflammatory lymphangiogenesis. Trends Immunol. 2012, 33:350-356.
59. Krishnan J., Kirkin V., Steffen A., Hegen M., Weih D., Tomarev S., Wilting J., Sleeman J.P. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res. 2003, 63:713-722.
60. Lee J.W., Epardaud M., Sun J., Becker J.E., Cheng A.C., Yonekura A.R., Heath J.K., Turley S.J. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 2007, 8:181-190.
61. Lin J., Lalani A.S., Harding T.C., Gonzalez M., Wu W.W., Luan B., Tu G.H., Koprivnikar K., VanRoey M.J., He Y., et al. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res. 2005, 65:6901-6909.
62. Lukacs-Kornek V., Malhotra D., Fletcher A.L., Acton S.E., Elpek K.G., Tayalia P., Collier A.R., Turley S.J. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat. Immunol. 2011, 12:1096-1104.
63. Lund A.W., Duraes F.V., Hirosue S., Raghavan V.R., Nembrini C., Thomas S.N., Issa A., Hugues S., Swartz M.A. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 2012, 1:191-199.
64. Luther S.A., Tang H.L., Hyman P.L., Farr A.G., Cyster J.G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12694-12699.
65. Magnusson F.C., Liblau R.S., von Boehmer H., Pittet M.J., Lee J.W., Turley S.J., Khazaie K. Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology 2008, 134:1028-1037.
66. Malhotra D., Fletcher A.L., Astarita J., Lukacs-Kornek V., Tayalia P., Gonzalez S.F., Elpek K.G., Chang S.K., Knoblich K., Hemler M.E., et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 2012, 13:499-510.
67. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001, 20:672-682.
68. Martin-Fontecha A., Lanzavecchia A., Sallusto F. Dendritic cell migration to peripheral lymph nodes. Handb. Exp. Pharmacol. 2009, 31-49.
69. Mashino K., Sadanaga N., Yamaguchi H., Tanaka F., Ohta M., Shibuta K., Inoue H., Mori M. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002, 62:2937-2941.
70. Matsui J., Funahashi Y., Uenaka T., Watanabe T., Tsuruoka A., Asada M. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin. Cancer Res. 2008, 14:5459-5465.
71. Mattila M.M., Ruohola J.K., Karpanen T., Jackson D.G., Alitalo K., Harkonen P.L. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer 2002, 98:946-951.
72. Minor G.R. A clinical and radiologic study of metastatic pulmonary neoplasms. J. Thorac. Surg. 1950, 20:34-42.
73. Miyazaki T., Okada N., Ishibashi K., Ogata K., Ohsawa T., Ishiguro T., Nakada H., Yokoyama M., Matsuki M., Kato H., et al. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer. Jpn. J. Clin. Oncol. 2008, 38:839-843.
74. Mohammed R.A., Green A., El-Shikh S., Paish E.C., Ellis I.O., Martin S.G. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br. J. Cancer 2007, 96:1092-1100.
75. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
76. Nagira M., Imai T., Hieshima K., Kusuda J., Ridanpaa M., Takagi S., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J. Biol. Chem. 1997, 272:19518-19524.
77. Nichols L.A., Chen Y., Colella T.A., Bennett C.L., Clausen B.E., Engelhard V.H. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J. Immunol. 2007, 179:993-1003.
78. Norder M., Gutierrez M.G., Zicari S., Cervi E., Caruso A., Guzman C.A. Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation. FASEB J. 2012, 26:2835-2846.
79. Ohtani O., Ohtani Y. Structure and function of rat lymph nodes. Arch. Histol. Cytol. 2008, 71:69-76.
80. Pepper M.S., Tille J.C., Nisato R., Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003, 314:167-177.
81. Podgrabinska S., Braun P., Velasco P., Kloos B., Pepper M.S., Skobe M. Molecular characterization of lymphatic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16069-16074.
82. Podgrabinska S., Kamalu O., Mayer L., Shimaoka M., Snoeck H., Randolph G.J., Skobe M. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J. Immunol. 2009, 183:1767-1779.
83. Qu C., Edwards E.W., Tacke F., Angeli V., Llodra J., Sanchez-Schmitz G., Garin A., Haque N.S., Peters W., van Rooijen N., et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 2004, 200:1231-1241.
84. Randolph G.J., Angeli V., Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 2005, 5:617-628.
85. Roberts N., Kloos B., Cassella M., Podgrabinska S., Persaud K., Wu Y., Pytowski B., Skobe M. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 2006, 66:2650-2657.
86. Rosen P.P. Rosen's Breast Pathology 2008, Lippincott Williams & Wilkins. 3rd edn.
87. Ruddell A., Kelly-Spratt K.S., Furuya M., Parghi S.S., Kemp C.J. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 2008, 27:3145-3155.
88. Saeki H., Moore A.M., Brown M.J., Hwang S.T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999, 162:2472-2475.
89. Schumann K., Lammermann T., Bruckner M., Legler D.F., Polleux J., Spatz J.P., Schuler G., Forster R., Lutz M.B., Sorokin L., Sixt M. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 2010, 32:703-713.
90. Schwab S.R., Cyster J.G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 2007, 8:1295-1301.
91. Shields J.D., Emmett M.S., Dunn D.B., Joory K.D., Sage L.M., Rigby H., Mortimer P.S., Orlando A., Levick J.R., Bates D.O. Chemokine-mediated migration of melanoma cells towards lymphatics-a mechanism contributing to metastasis. Oncogene 2007, 26:2997-3005.
92. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7:192-198.
93. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., Achen M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 2001, 7:186-191.
94. Swartz M.A., Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc. Res. Tech. 2001, 55:92-99.
95. Tal O., Lim H.Y., Gurevich I., Milo I., Shipony Z., Ng L.G., Angeli V., Shakhar G. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 2011, 208:2141-2153.
96. Tewalt E.F., Cohen J.N., Rouhani S.J., Engelhard V.H. Lymphatic endothelial cells - key players in regulation of tolerance and immunity. Front. Immunol. 2012, 3:305.
97. Tewalt E.F., Cohen J.N., Rouhani S.J., Guidi C.J., Qiao H., Fahl S.P., Conaway M.R., Bender T.P., Tung K.S., Vella A.T., et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 2012, 120:4772-4782.
98. Thomas A., Lenox R. Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult. CMAJ 2008, 179:338-340.
99. Thurlbeck W.M. Neoplasia of the pulmonary vascular bed. Pulmonary Vascular Disease 1979, Marcel Dekker, New York. K.M. Moser (Ed.).
100. Tomashefski J.F., Dail D.H. Dail and Hammar's Pulmonary Pathology 2008, Springer, New York. 3rd edn.
101. Topalian S.L., Hodi F.S., Brahmer J.R., Gettinger S.N., Smith D.C., McDermott D.F., Powderly J.D., Carvajal R.D., Sosman J.A., Atkins M.B., et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 2012, 366:2443-2454.
102. Trapnell D.H. Radiological appearances of lymphangitis carcinomatosa of the lung. Thorax 1964, 19:251-260.
103. Tsutsumi S., Kuwano H., Shimura T., Morinaga N., Mochiki E., Asao T. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer. Hepatogastroenterology 2005, 52:629-632.
104. Uchida D., Onoue T., Tomizuka Y., Begum N.M., Miwa Y., Yoshida H., Sato M. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol. Cancer Res. 2007, 5:685-694.
105. Van den Eynden G.G., Van der Auwera I., Van Laere S.J., Huygelen V., Colpaert C.G., van Dam P., Dirix L.Y., Vermeulen P.B., Van Marck E.A. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. Br. J. Cancer 2006, 95:1362-1366.
106. Van den Eynden G.G., Vandenberghe M.K., van Dam P.J., Colpaert C.G., van Dam P., Dirix L.Y., Vermeulen P.B., Van Marck E.A. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin. Cancer Res. 2007, 13:5391-5397.
107. Vona G., Sabile A., Louha M., Sitruk V., Romana S., Schutze K., Capron F., Franco D., Pazzagli M., Vekemans M., et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am. J. Pathol. 2000, 156:57-63.
108. Weber M., Hauschild R., Schwarz J., Moussion C., de Vries I., Legler D.F., Luther S.A., Bollenbach T., Sixt M. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 2013, 339:328-332.
109. Wiley H.E., Gonzalez E.B., Maki W., Wu M.T., Hwang S.T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. 2001, 93:1638-1643.
110. Willimann K., Legler D.F., Loetscher M., Roos R.S., Delgado M.B., Clark-Lewis I., Baggiolini M., Moser B. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 1998, 28:2025-2034.
111. Yamaguchi H., Wyckoff J., Condeelis J. Cell migration in tumors. Curr. Opin. Cell Biol. 2005, 17:559-564.
112. Yanai Y., Furuhata T., Kimura Y., Yamaguchi K., Yasoshima T., Mitaka T., Mochizuki Y., Hirata K. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. J. Exp. Clin. Cancer Res. 2001, 20:419-428.
113. Yang S.P., Lin C.C. Lymphangitic carcinomatosis of the lungs. The clinical significance of its roentgenologic classification. Chest 1972, 62:179-187.
114. Zheng W., Aspelund A., Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J. Clin. Invest. 2014, 124:878-887.